CHINAVTM MINING (00893) announces annual performance, with a net loss of 142,000 yuan attributable to shareholders, a year-on-year decrease of 99.31%.
China Iron & Titanium (00893) announced its annual performance for the year ending on December 31, 2025. The Group achieved a revenue of 558 million yuan during the period, an increase of 2.84% year-on-year. The company's attributable loss narrowed to 142,000 yuan, a decrease of 99.31% year-on-year, with a basic loss per share of 0.01 points.
CHINAVTM MINING (00893) announced its annual performance for the year ended December 31, 2025. The group achieved revenue of 558 million yuan, an increase of 2.84% year-on-year. The loss attributable to owners of the company was 142,000 yuan, a decrease of 99.31% year-on-year. Basic loss per share was 0.01 cent.
Related Articles

GLOBAL BIO-CHEM (00809) has released its annual performance, with an annual profit of HK$156 million, a decrease of 79.69% year-on-year.

RAILY AESMED (02135): Lin Hai appointed as an independent non-executive director of the company.

RAILY AESMED (02135) announces annual performance, with net profit attributable to shareholders of 1.873 million yuan, turning loss into profit year-on-year.
GLOBAL BIO-CHEM (00809) has released its annual performance, with an annual profit of HK$156 million, a decrease of 79.69% year-on-year.

RAILY AESMED (02135): Lin Hai appointed as an independent non-executive director of the company.

RAILY AESMED (02135) announces annual performance, with net profit attributable to shareholders of 1.873 million yuan, turning loss into profit year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


